Hofstra University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Hempstead NY United States (1935)

Organization Overview

First Clinical Trial
2010
NCT01180816
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Hofstra North Shore | Hofstra Northwell School of Medicine

Active Ingredients

Drugs in Phase 3 Trials (1)

aqx-1125 (1 trial)

Drugs in Phase 2 Trials (1)

estradiol (progynon depot) (1 trial)

Drugs in Phase 1 Trials (2)

bevacizumab (avastin) (1 trial)

temozolomide (temodar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Astrocytoma (Phase 1)

Atrophy (Phase 2)

Cystitis (Phase 3)

Cystitis, Interstitial (Phase 3)

Glioblastoma (Phase 1)

Neurilemmoma (Phase 1)

Neuroma, Acoustic (Phase 1)

Pelvic Organ Prolapse (Phase 2)

Somatoform Disorders (Phase 3)

Syndrome (Phase 3)

Ulcer (Phase 2)

Vaginitis (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 4